Dec 4, 2024
The clinical trial aims to evaluate the efficacy of a novel drug combination in treating neuroblastoma, a rare and challenging pediatric cancer.
Oct 8, 2024
For the 14th consecutive year, Penn State Health Children’s Hospital has earned recognition from U.S. News & World Report for its exceptional patient care.
Sep 30, 2024
A study aims to evaluate the investigational drug, silmitasertib, in combination with FDA-approved drugs for solid tumors.
Sep 25, 2024
Dr. Sinisa Dovat has been awarded a $4 million grant to advance his research in pediatric oncology.
Sep 4, 2024
For two decades, Dr. Giselle Saulnier Sholler has made saving the lives of children faced with an aggressive cancer called neuroblastoma her life's mission.
Aug 28, 2024
Hyundai Hope on Wheels is supporting pediatric oncology research at Penn State College of Medicine.
Jul 17, 2024
Giselle Saulnier Sholler, director of pediatric oncology research, discusses her quest to transform cancer care
Feb 5, 2024
When dancers take the floor at THON, one of the outcomes they're dancing for is Ernesto Garcia, medical interpreter in the pediatric hematology-oncology unit at Penn State Health Children's Hospital.
Dec 20, 2023
The U.S. Food and Drug Administration has approved the first drug — based on Giselle Saulnier Sholler's research and clinical trials — to reduce the risk of relapse for pediatric high-risk neuroblastoma patients.
Dec 1, 2023
Penn State Cancer Institute researcher Stuthi Perimbeti, MD, has received the Robert A. Winn Diversity in Clinical Trials Career Development Award.